A. Duncan

发表

Therapeutic plasma exchange for COVID‐19‐associated hyperviscosity

S. Stowell, J. Guarner, C. Kempton, 2020, Transfusion.

Overview of pharmacogenetics in anticoagulation therapy.

C. Hill, A. Duncan, 2008, Clinics in laboratory medicine.

Detection and identification of cytochrome P-450 2C9 alleles *1, *2, and *3 by high-resolution melting curve analysis of PCR amplicons.

F. Nolte, C. Hill, A. Duncan, 2006, American journal of clinical pathology.

The Utility of the Markers of Coagulation and Hemostatic Activation Profile in the Management of Embolic Strokes of Undetermined Source.

S. Rangaraju, S. Belagaje, F. Nahab, 2021, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Markers of coagulation and hemostatic activation aid in identifying causes of cryptogenic stroke

S. Rangaraju, S. Belagaje, F. Nahab, 2020, Neurology.

Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis?

H. Khoury, A. Winkler, M. Arellano, 2012, Chest.

Coagulation markers and echocardiography predict atrial fibrillation, malignancy or recurrent stroke after cryptogenic stroke

S. Rangaraju, S. Belagaje, F. Nahab, 2018, Medicine.

COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?

Derek M Polly, S. Auld, C. Maier, 2020, The Lancet.

Anticoagulation Therapy Reduces Recurrent Stroke in Embolic Stroke of Undetermined Source Patients With Elevated Coagulation Markers or Severe Left Atrial Enlargement

S. Rangaraju, S. Belagaje, F. Nahab, 2021, Frontiers in Neurology.

Malignant angioendotheliomatosis presenting as disseminated intravascular coagulopathy

C. Corley, R. Stahl, A. Duncan, 1991, Cancer.

Psychosocial Impact and Disease Management in Patients with Congenital Factor VII Deficiency

D. Cooper, A. Duncan, S. Peltier, 2020, Journal of blood medicine.

Serum hyaluronic acid in patients with veno-occlusive disease following bone marrow transplantation

A. Farrand, M. Fried, J. Peter, 2001, Bone Marrow Transplantation.

Antithrombin deficiency: issues in laboratory diagnosis.

K. Kottke-Marchant, A. Duncan, 2002, Archives of pathology & laboratory medicine.

Chemotherapy‐induced hemolytic uremic syndrome: Description of a potential animal model

C. Hillyer, H. McClure, T. Barrett, 1995, Journal of medical primatology.

Therapy of the Kasabach‐Merritt syndrome with cryoprecipitate plus intra‐arterial thrombin and aminocaproic acid

J. Henderson, Louis G. Martin, R. Stahl, 1991, American journal of hematology.

A hypercoagulable state follows orthotopic liver transplantation

W. Millikan, J. Henderson, W. D. Warren, 1990, Hepatology.

Chapter 25 – Coagulation Factor Preparations

J. Zimring, A. Duncan, 2007 .

Pharmacogenetics in Oral Antithrombotic Therapy.

C. Hill, C. Maier, A. Duncan, 2016, Clinics in laboratory medicine.

Randomized trial to evaluate the clinical benefits of serum alpha-glutathione S-transferase concentration monitoring after liver transplantation.

G. Alexander, A. Gimson, P. Friend, 1997, Transplantation.

Prophylactic use of factor IX concentrate in a Jehovah's Witness patient.

Kenichi A. Tanaka, F. Szlam, E. Chen, 2009, The Annals of thoracic surgery.

A hypercoagulable state follows orthotopic liver transplantation.

W. Millikan, J. Henderson, W. D. Warren, 1991, Hepatology.

Dengue virus-induced hemorrhage in a nonhuman primate model.

G. Perng, F. Villinger, S. Noisakran, 2010, Blood.

Successful ABO‐incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresis

J. Spivey, R. Romero, T. Heffron, 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

COVID-19-Associated Hyperviscosity: A Potential Link between Inflammation and Thrombophilia

Derek M Polly, S. Auld, C. Maier, 2020 .

Evaluation of Interventions to Reduce Child Mortality From Acute Respiratory Infections in a Remote Community in North Eastern Afghanistan, and the Implications for the Emergence of Antibiotic Resistance in Streptococcus pneumoniae

A. Duncan, 2011 .

Elevated D dimer in the lungs and blood of patients with sarcoidosis.

R. Hunter, A. Duncan, G. Staton, 1993, Chest.

Validation of an admission coagulation panel for risk stratification of COVID-19 patients

J. Guarner, S. Rangaraju, C. Kempton, 2021, PloS one.

Disease Burden in Patients with Glanzmann’s Thrombasthenia: Perspectives from the Glanzmann’s Thrombasthenia Patient/Caregiver Questionnaire

D. Cooper, A. Duncan, S. Peltier, 2019, Journal of blood medicine.

THROMBOCYTOPENIA CAUSED BY FRUSEMIDE-INDUCED PLATELET ANTIBODY

S. Moore, A. Duncan, P. Barker, 1981, The Lancet.

PREVELANCE OF PRIMARY COAGULATION DEFICIENCIES IN PATIENTS WITH DEEP VENOUS THROMBOSIS

B. Grossman, A. Duncan, 1987, Thrombosis and Haemostasis.

Congenital afibrogenaemia in a Kenyan child: case report.

A. Duncan, G. Kitonyi, J. Rajab, 2010, East African medical journal.

Dengue virus-induced hemorrhage in a nonhuman primate model.

G. Perng, F. Villinger, S. Noisakran, 2010, Blood.